By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Apogenix 

Im Neuenheimer Feld 584

Heidelberg    69120  Germany
Phone: 49-0-6221-58608-0 Fax: 49-0-6221-58608-10


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Apogenix To Present At Two Upcoming International Conferences 5/4/2016 9:34:36 AM
Apogenix To Present At Two Upcoming International Conferences 5/4/2016 9:15:06 AM
Preclinical Efficacy Data Of Apogenix' APG101 In Myelodysplastic Syndromes (MDS) Published In Oncotarget 3/24/2016 7:16:19 AM
Apogenix Receives €3 Million Grant For The Development Of A Companion Diagnostic Test For Lead Immuno-Oncology Candidate APG101 2/16/2016 9:06:25 AM
Apogenix Strengthens U.S. Patent Position For Lead Immuno-Oncology Candidate APG101 1/14/2016 7:40:55 AM
Apogenix Receives First Milestone Payment From CANbridge Licensing Agreement And Signs Amendment To Include Taiwan 1/7/2016 7:39:21 AM
Apogenix To Present At J.P. Morgan Healthcare Conference 12/15/2015 10:34:29 AM
Apogenix To Present At Three Upcoming International Conferences 10/13/2015 10:32:47 AM
Apogenix Enters Into Cooperation With R-Biopharm To Develop Companion Diagnostic Tests For Immuno-Oncology Candidate APG101 7/28/2015 9:05:27 AM
Canbridge Acquires License For Apogenix’s APG101 Onco-Immunotherapy In Glioblastoma For China 7/15/2015 9:51:16 AM
123
//-->